[1]
2013. Modern possibilities of targeted therapy in the treatment of breast cancer patients with overexpression of HER-2/neu and metastatic damage of the brain. Voprosy onkologii. 59, 3 (Dec. 2013), 347–351. DOI:https://doi.org/10.37469/0507-3758-2013-59-3-347-351.